Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting

Pfizer just gave income investors four reasons to like its juicy dividend even more.Income investors usually don't mind too much if a stock doesn't deliver tremendous gains, as long as it keeps the dividends flowing. They typically don't like it when a stock tumbles, though, as Pfizer (PFE +1.38%) has done this year.But Pfizer's juicy forward dividend yield of 7% offsets most of the year-to-date decline. The company also reported good news in its third-quarter update earlier this week. Here are four reasons ...